Healthy Hearts: Leveraging the Diabetes Prevention Program to Decrease Health Disparities in Women of Reproductive Age
- Conditions
- Gestational Weight GainOverweight or ObesityPrediabetic StateHypertension
- Interventions
- Behavioral: Diabetes Prevention Program (DPP)Behavioral: Diabetes Prevention Program Plus (DPP+)
- Registration Number
- NCT05379296
- Brief Summary
Nearly half of women have obesity and/or hypertension (HTN). Specific to women, pregnancy creates a vulnerable window for excess gestational weight gain (GWG), exacerbating intergenerational risks for obesity, HTN, type 2 diabetes (T2D), and cardiovascular disease (CVD) across the lifespan. Healthy lifestyles are the first-line recommendations for prevention and treatment of overweight/obesity, HTN, T2D, and CVD. The Diabetes Prevention Program (DPP) is a well-established, Centers for Disease Control and Prevention (CDC)-led public health program focusing on healthy lifestyle changes and is effective at reducing 5-7% of body weight, lowering risks for T2D. Interestingly, research investigating the DPP as a lifestyle intervention for other chronic conditions (i.e., overweight/obesity and HTN) is lacking, demonstrating a missed opportunity. The aim of this study is to determine the initial effects of the first 6-months and after receiving the full 12-months of the virtual DPP compared to the DPP expanded with a CDC-approved HTN prevention component (DPP+) on physical activity, diet, weight, and CVD risk factors in 30 prediabetic women (18-45 years old) with a history of excess GWG, overweight/obesity, and HTN. Participants will be recruited through University of Texas Medical Branch (UTMB) community-based clinics using Epic. The Participants will be randomized into 2 groups (DPP and DPP+) and guided through the 12-month virtual DPP or DPP+ program using UTMB DPP personnel.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
- Women with prediabetes and eligible for the DPP, overweight/obesity, HTN (diagnosed or 3 successive high blood pressure readings), and history of excess gestational weight gain during most recent pregnancy
- Pregnant and lactating women, participants planning to move out of Galveston County within the next year
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Diabetes Prevention Program (DPP) Diabetes Prevention Program (DPP) CDC-approved 12-month DPP virtual lifestyle program Diabetes Prevention Program Plus (DPP+) Diabetes Prevention Program Plus (DPP+) CDC-approved 12-month DPP virtual lifestyle program expanded to include a CDC-approved module on hypertension prevention and treatment
- Primary Outcome Measures
Name Time Method Change from Baseline Low-density lipoproteins at 12 months Baseline, 12-months Change from Baseline Systolic Blood Pressure at 6 months Baseline, 6-months Change from Baseline High-density lipoproteins at 6 months Baseline, 6-months Change from Baseline Low-density lipoproteins at 6 months Baseline, 6-months Change from Baseline Systolic Blood Pressure at 12 months Baseline, 12-months Change from Baseline Diastolic Blood Pressure at 6 months Baseline, 6-months Change from Baseline Diastolic Blood Pressure at 12 months Baseline, 12-months Change from Baseline Total cholesterol at 6 months Baseline, 6-months Change from Baseline High-density lipoproteins at 12 months Baseline, 12-months Change from Baseline Fasting blood glucose at 6 months Baseline, 6-months Change from Baseline Triglycerides at 6 months Baseline, 6-months Change from Baseline Triglycerides at 12 months Baseline, 12-months Change from Baseline Total cholesterol at 12 months Baseline, 12-months Change from Baseline Hemoglobin a1c at 6 months Baseline, 6-months Change from Baseline Weight at 12 months Baseline, 12-months Change from Baseline Fasting blood glucose at 12 months Baseline, 12-months Change from Baseline Hemoglobin a1c at 12 months Baseline, 12-months Change from Baseline Weight at 6 months Baseline, 6-months Change from Baseline Body mass index at 12 months Baseline, 12-months Change from Baseline Body mass index at 6 months Baseline, 6-months Change from Baseline Serum insulin at 6 months Baseline, 6-months Change from Baseline Serum insulin at 12 months Baseline, 12-months
- Secondary Outcome Measures
Name Time Method Change from Baseline Total portions of Fried Food Consumption at 12 months Baseline, 12-months Measured using the PreventT2 Diabetes Prevention Program questionnaire
Change from Baseline Subjective Weekly Physical activity at 12 months Baseline, 12-months Stanford Brief Leisure-Time Activity Categorical Item (L-CAT 2.2)
Change from Baseline Objective Total Weekly Physical activity minutes at 12 months Baseline, 12-months Measured using Fitbit Inspire 2
Change from Baseline C-reactive protein at 6 months Baseline, 6-months Change from Baseline Visceral adiposity tissue at 12 months Baseline, 12-months Measured using Dual energy X-ray absorptiometry
Change from Baseline Total portions of Combined Weekly Fruit and Vegetable Consumption at 12 months Baseline, 12-months Measured using the PreventT2 Diabetes Prevention Program questionnaire
Change from Baseline Total portions of Fried Food Consumption at 6 months Baseline, 6-months Measured using the PreventT2 Diabetes Prevention Program questionnaire
Change from Baseline Subjective Weekly Physical activity at 6 months Baseline, 6-months Stanford Brief Leisure-Time Activity Categorical Item (L-CAT 2.2)
Change from Baseline Total portions of Combined Weekly Fruit and Vegetable Consumption at 6 months Baseline, 6-months Measured using the PreventT2 Diabetes Prevention Program questionnaire
Change from Baseline Objective Total Weekly Physical activity minutes at 6 months Baseline, 6-months Measured using Fitbit Inspire 2
Change from Baseline Visceral adiposity tissue at 6 months Baseline, 6-months Measured using Dual energy X-ray absorptiometry
Change from Baseline C-reactive protein at 12 months Baseline, 12-months